PMID: 9004744Nov 1, 1996Paper

Depression and Parkinson's disease: neurobiologic foundations and therapeutic management

Neurología : publicación oficial de la Sociedad Española de Neurología
S Giménez-RoldánM Giménez-Zuccarelli

Abstract

The prevalence of depression in Parkinson's disease (PD) is estimated to be around 40% and generally takes the form of dysthymia. Although psychological factors probably contribute to depression, data point to a relation to structural and biochemical changes linked to PD. Thus, the onset of motor impairment is often preceded by a depressive episode, although there is no consistency between the seriousness of motor disability and depression. Furthermore, depression aggravates the memory and language impairments of PD and is thought to be a risk factor for developing dementia. Regional cerebral blood flow abnormalities in the medial frontal and cingulate cortices and low 5-HIIA concentrations in cerebro-spinal fluid suggest that degeneration of the mesocorticolimbic dopaminergic system as well as dorsal raphe changes may be implicated. Assessment of depression in PD is difficult, as none of the currently available scales were specifically designed for patients with this disease Furthermore, there is a lack of well-controlled studies showing that current antidepressants are effective in PD patients or are safe for use when the motor, cognitive and autonomic impairments of PD are present.

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Amy L ByersKristine Yaffe
Journal of Affective Disorders
P ThomasM Goudemand
Movement Disorders : Official Journal of the Movement Disorder Society
Laura MarshNINDS/NIMH Work Group on Depression and Parkinson's Disease
© 2022 Meta ULC. All rights reserved